GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CPRX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Catalyst Pharmaceuticals stock price ended at $15.13 on Friday, after losing 1.37%.
(Updated on Apr 19, 2024)

Sell candidate since Apr 18, 2024 Loss -1.37% PDF

The Catalyst Pharmaceuticals stock price fell by -1.37% on the last day (Friday, 19th Apr 2024) from $15.34 to $15.13. During the last trading day the stock fluctuated 5.12% from a day low at $15.03 to a day high of $15.80. The price has risen in 6 of the last 10 days but is still down by -0.26% for this period. Volume has increased on the last day by 4 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 5 million shares were bought and sold for approximately $80.11 million.

The stock lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $14.80 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 13.65% during the next 3 months and, with a 90% probability hold a price between $16.82 and $20.70 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CPRX Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, April 04, 2024, and so far it has risen 0.0661%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Catalyst Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $15.49 and $15.94. A break-up above any of these levels will issue buy signals. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Catalyst Pharmaceuticals stock

Catalyst Pharmaceuticals finds support from accumulated volume at $14.56 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.770 (5.12%) between high and low. For the last week, the stock has had daily average volatility of 4.15%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CPRX) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Catalyst Pharmaceuticals to open at $15.32, and during the day (based on 14 day Average True Range), to move between $14.49 and $15.77, which gives a possible trading interval of +/-$0.638 (+/-4.22%) up or down from last closing price. If Catalyst Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 8.44% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $14.56 (3.77%) than the resistance at $16.03 (5.95%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Catalyst Pharmaceuticals stock A Buy?

The Catalyst Pharmaceuticals stock holds several negative signals and despite the positive trend, we believe Catalyst Pharmaceuticals will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -1.136 Sell Candidate Unchanged

Predicted Opening Price for Catalyst Pharmaceuticals of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$15.32 ( 1.26%) $15.13

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CPRX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 16.09 6.35 %
R2 15.80 4.40 %
R1 15.61 3.20 %
Current price: 15.13
Support S1 15.03 -0.688 %
S2 14.84 -1.89 %
S3 14.55 -3.83 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 17.01 12.43 %
R2 16.07 6.21 %
R1 16.03 5.95 %
Current price 15.13
Support S1 14.56 -3.77%
S2 13.64 -9.85%
S3 13.18 -12.89%

FAQ

What is the symbol for Catalyst Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Catalyst Pharmaceuticals is CPRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Catalyst Pharmaceuticals Stock?
The Catalyst Pharmaceuticals stock holds several negative signals and despite the positive trend, we believe Catalyst Pharmaceuticals will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Catalyst Pharmaceuticals Stock?
Catalyst Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Catalyst Pharmaceuticals Stock.

What's the current price of Catalyst Pharmaceuticals Stock?
As of the end of day on the 2024-04-19, the price of an Catalyst Pharmaceuticals (CPRX) share was $15.13.

What is the 52-week high and low for Catalyst Pharmaceuticals Stock?
The 52-week high for Catalyst Pharmaceuticals Stock is $17.77 and the 52-week low is $11.09.

What is the market capitalization of Catalyst Pharmaceuticals Stock?
As of the 2024-04-19, the market capitalization of Catalyst Pharmaceuticals is 1.783B.

When is the next earnings date for Catalyst Pharmaceuticals?
The upcoming earnings date for Catalyst Pharmaceuticals is May 08, 2024.
Click to get the best stock tips daily for free!

About Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develop... CPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT